A highly efficient non-viral process for programming mesenchymal stem cells for gene directed enzyme prodrug cancer therapy
10.1038/s41598-020-71224-2
Saved in:
Main Authors: | Ho, Y.K., Woo, J.Y., Tu, G.X.E., Deng, L.-W., Too, H.-P. |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Article |
Published: |
Nature Research
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199649 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
NON-VIRAL GENE MODIFIED MESENCHYMAL STEM CELLS FOR GENE-DIRECTED ENZYME PRODRUG THERAPY
by: GERALDINE TU XUE EN
Published: (2019) -
TOWARDS CLINICAL TRANSLATION OF NON-VIRALLY GENE MODIFIED MESENCHYMAL STEM CELLS FOR CELL-DIRECTED ENZYME PRODRUG THERAPY
by: WOO JUN YUNG
Published: (2023) -
Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma
by: Bak, X.Y., et al.
Published: (2014) -
A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth
by: Tu, G.X.E., et al.
Published: (2021) -
COMPARISON OF CYTOSINE DEAMINASE/5-FLUOROCYTOSINE VERSUS HERPES SIMPLEX VIRUS THYMIDINE KINASE/GANCICLOVIR ENZYME/PRODRUG SYSTEMS IN GLIOBLASTOMA GENE THERAPY.
by: YE KAI
Published: (2012)